Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-01

Study Completion Date

2021-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities

NCT05011344

Covid19

UNKNOWN NA

Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)

NCT05125887

SARS-CoV2 Infection

UNKNOWN

Primary Care in AURA for COVID-19

NCT05124145

Primary Care : Suspected and Confirmed Cases of COVID-19 Primary Health Care COVID-19 Pandemic

COMPLETED

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)

NCT04779424

SARS-CoV-2 COVID-19

COMPLETED

Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19

NCT05128656

COVID-19

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In France during the first wave of the pandemic, 30,230 symptomatic healthcare workers had been reported positive. Yet, the prevalence of the infection in French healthcare workers remains unknown as it mostly reflect symptomatic infections.

Also, the prevalence of infection was reported being higher in male healthcare workers, and in those having patients' facing roles. However, the impact of the level of exposure to SARS-CoV-2, the use of personal protective equipment and hospital organization to prevent infection and spread remains unclear.

Our study aims to report the seroprevalence of SARS-CoV-2 infection among French healthcare workers after the first wave of the pandemic. It also aims to explore the impact of the type of occupations and the level of exposure to the viruses on the seroprevalence of infection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Health Care Worker

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospital staff employee
* Employed in one of the participating centers
* Volunteers to perform SARS-CoV-2 serology
* Permanent or occasional staff (temporary workers, short contracts)
* Caregivers or not (medical, paramedical, administrative, technical staff)

Exclusion Criteria

* Staff who are not working at a participating center while participating in the study
* Person under guardianship or curatorship
* Opposition to data collection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No